Contact history

The history of contact with confirmed patients

60 (42.0%)

46 (41.8%)

14 (42.4%)

The history of contact with epidemic area

70 (49.0%)

54 (49.1%)

16 (48.5%)

Unknown

9 (6.3%)

6 (5.5%)

3 (9.1%)

Both

4 (2.8%)

4 (3.6%)

0 (0%)

Temperature (˚C)

<37.5

1 (0.7%)

1 (0.9%)

0 (0%)

37.5 - 38

7 (4.9%)

7 (6.4%)

0 (0%)

38 - 38.5

39 (27.3%)

29 (26.4%)

10 (30.3%)

38.5 - 39

26 (18.2%)

19 (17.3%)

7 (21.2%)

39 - 40

32 (22.4%)

20 (18.2%)

12 (36.4%)

>40

1 (0.7%)

1 (0.9%)

0 (0%)

Unknown

37 (25.9%)

33 (30.0%)

4 (12.1%)

Clinical symptoms

Fever

105 (73.4%)

76 (53.1%)

29 (20.1%)

Coughing of phlegm

41 (28.7%)

30 (27.3%)

11 (33.3%)

Dry cough

42 (29.4%)

30 (27.3%)

12 (36.4%)

Yellow sputum

8 (5.6%)

6 (5.5%)

2 (6.1%)

Sore throat

15 (10.5%)

12 (10.9%)

3 (9.1%)

Nasal obstruction

8 (5.6%)

8 (7.3%)

0 (0%)

Muscle soreness

14 (9.8%)

11 (10.0%)

3 (9.1%)

Weak

37 (25.9%)

31 (28.2%)

6 (18.2%)

Chest distress

25 (17.5%)

17 (15.5%)

8 (24.2%)

Coexisting disorders

hypertension

20 (14.0%)

15 (13.6%)

5 (15.2%)

diabetes

12 (8.4%)

7 (6.4%)

5 (15.2%)

COPD

3 (2.1%)

2 (1.8%)

1 (3.0%)

The incubation period (days)

<3

3 (2.1%)

3 (2.7%)

0 (0%)

3 - 6

10 (7%)

9 (7.3%)

1 (3.0%)

6 - 9

10 (7%)

9 (8.1%)

1 (3.0%)

9 - 12

6 (4.2%)

3 (2.7%)

3 (9.1%)

>15

4 (2.8%)

4 (3.6%)

0 (0%)

Unknown

110 (76.9%)

82 (74.5%)

28 (84.8%)

Treatment delay

<1

49 (34.3%)

8 (24.2%)

41 (37.3%)

1 - 2

40 (28.0%)

8 (24.2%)

32 (29.1%)

2 - 5

22 (15.4%)

6 (18.2%)

16 (14.5%)

5 - 10

16 (11.2%)

7 (21.2%)

9 (8.2%)

>10

2 (1.4%)

2 (6.1%)

0 (0%)

Unknown

14 (9.8%)

2 (6.1%)

12 (10.9%)